2020
DOI: 10.1007/s00520-020-05779-1
|View full text |Cite
|
Sign up to set email alerts
|

“I think that a brief conversation from their provider can go a very long way”: Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 46 publications
0
7
0
Order By: Relevance
“…Table 2 lists the titles, authors, and countries for each of the 24 included studies [ 16 , 17 , 18 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ]. Table 1 also includes, for each study, the genetic disease focus or foci of each study (regarding PROs following genetic testing for breast and ovarian cancer syndrome, Lynch syndrome, and/or FH) and whether the study was qualitative, quantitative, or mixed-methods in nature.…”
Section: Resultsmentioning
confidence: 99%
“…Table 2 lists the titles, authors, and countries for each of the 24 included studies [ 16 , 17 , 18 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ]. Table 1 also includes, for each study, the genetic disease focus or foci of each study (regarding PROs following genetic testing for breast and ovarian cancer syndrome, Lynch syndrome, and/or FH) and whether the study was qualitative, quantitative, or mixed-methods in nature.…”
Section: Resultsmentioning
confidence: 99%
“…Patients were asked to report all primary cancer types, date of cancer diagnosis, treatment received, and genetic testing status. The PHQ-4 was used to measure anxiety and depression; respondents scores were dichotomized by either none (0-2) or mild to severe (3)(4)(5)(6)(7)(8)(9)(10)(11)(12). 25 As part of the survey, participants were asked if they had undergone cancer genetic testing.…”
Section: Methodsmentioning
confidence: 99%
“…Patient‐level factors, defined as factors impacting or perceived by an individual patient, include lack of provider referral and concerns about cost, clinical utility, privacy and confidentiality, and logistical issues. 8 , 9 , 10 , 11 The provider reported barriers to testing include perceived patient disinterest, long wait times for genetic services, insurance coverage concerns, unknown guidelines for management, insufficient experience/training, and clinical time limitations. 12 , 13 , 14 , 15 Systemic barriers include reduced access to specialists for under‐ and uninsured patients, health system mistrust, and lack of pre‐symptomatic genetic testing with public insurance.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The PRECEDE constructs from the PRECEDE–PROCEED model developed by Green and Kreuter (2005) have previously been used as a framework by studies within different scientific fields, including oral health, that have examined factors that precede a behaviour (Dharamsi et al, 2009; Mallen et al, 2021). PRECEDE in the model stands for Predisposing, Reinforcing, and Enabling Constructs in terms of Educational Diagnosis and Evaluation, while PROCEDE stands for Policy, Regulatory, and Organisational Constructs in Educational and Environmental Development (Green & Kreuter, 2005).…”
Section: Introductionmentioning
confidence: 99%